IGTG - Ingen Technologies, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGTG - Ingen Technologies, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: seantrade	1/17/2006 2:30:21 PM
	Read Replies (1) of 581

interesting post from hotstockmarket.com For 2006, Ingen projects to penetrate 10% of the market for OxyView and realize revenues of roughly $15M (hospital and outpatient revenue combined). If Ingen only realizes HALF of their OxyView goal for 2006, they pull in $7.5M (not including revenues from Secure Balance, etc). If you assume a conservative profit margin of 30%, that gives you a company that makes $2M+ on OxyView alone this year. The current market cap is still only $2.5M making for at least a nice triple jmo. Forward revenue projections for OxyView: fsnews.findlaw.com .24 x .26 (2x1) one MM to .27 FLOAT=> 11Million __________________

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next